共 111 条
[1]
Holohan C(2013)Cancer drug resistance: an evolving paradigm Nat Rev Cancer 13 714-26
[2]
Van Schaeybroeck S(2010)How to improve R&D productivity: the pharmaceutical industry’s grand challenge Nat Rev Drug Discov 9 203-14
[3]
Paul SM(2012)Drug repositioning for personalized medicine Genome Med 4 27-993
[4]
Mytelka DS(2008)The use of genomics in clinical trial design Clin Cancer Res 14 5984-50
[5]
Li YY(2011)Genomics and the continuum of cancer care N Engl J Med 364 340-24
[6]
Jones S(2011)The evolving war on cancer Cell 145 19-7
[7]
Simon R(2011)Predictive, personalized, preventive, participatory (P4) cancer medicine Nat Rev Clin Oncol 8 184-91
[8]
McDermott U(2012)Preparing for precision medicine N Engl J Med 366 489-8
[9]
Downing JR(2012)Navigating cancer network attractors for tumor-specific therapy Nat Biotechnol 30 842-313
[10]
Haber DA(2014)Principles and methods of integrative genomic analyses in cancer Nat Rev Cancer 14 299-1307